Man Group’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-59,338
Closed -$411K 2359
2024
Q4
$411K Buy
59,338
+15,059
+34% +$110K ﹤0.01% 1716
2024
Q3
$257K Buy
44,279
+8,432
+24% +$51.2K ﹤0.01% 1801
2024
Q2
$191K Buy
35,847
+10,376
+41% +$47.7K ﹤0.01% 1903
2024
Q1
$96.8K Buy
+25,471
New +$92.3K ﹤0.01% 2067
2022
Q4
Sell
-11,175
Closed -$140K 2204
2022
Q3
$140K Buy
+11,175
New +$134K ﹤0.01% 1823
2022
Q2
Hold
0
1905

Other funds holding SRTS

Man Group's SRTS Position: Q1 2025 in Review

Man Group sold out of Sensus Healthcare (SRTS) in Q1 2025, closing a stake of 59,338 shares — an estimated $411K sold.

Man Group first reported a position in SRTS in Q3 2022 and held it in 5 quarters. The position peaked at $411K in Q4 2024. 53 funds tracked by Wall St. Rank hold SRTS as of Q1 2025.

  • Man Group reported no remaining Sensus Healthcare position as of Q1 2025 after selling out during the quarter.
  • Man Group sold 59,338 Sensus Healthcare shares in Q1 2025, an estimated $411K.
  • Man Group first reported a position in Sensus Healthcare in Q3 2022 and held it in 5 quarters.
  • Man Group's Sensus Healthcare position peaked at $411K in Q4 2024.
  • 53 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2025.

Based on Man Group's 13F filing for Q1 2025, filed 15 May 2025.